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Background: Pre-eclampsia (PE) is a gestational disease featured by hypertension, arterial systemic vasculopathy,
multiple organ failure and fetal compromise.
The aim of the investigation was to determine the role of maternal respiratory sinus arrhythmia (RSA) in regulation
of the fetal circulatory system in case of healthy pregnancy and in PE.
Methods: The investigation of maternal and fetal HRV and fetal CTG variables in 106 patients at 34–40 weeks of
gestation was performed. 30 of them had healthy pregnancy and were involved in the Group I. In Group II 44
pregnant women with mild-moderate PE were observed. 32 patients with severe PE were monitored in Group III.
Result: The maternal sympathetic overactivity modulated HRV in PE by suppressing total power (TP) and
parasympathetic tone. The lack of RSA was explored in preeclamptic patients. The centralization of hemodynamics
was a result of the hypersympatheticotonia in severe PE. Fetal circulatory response to PE featured by an increased
sympathetic tone. The modulated fetal CTG variables captured the suppression of fetal biophysical activity and the
development of fetal distress in severe PE.
Strong relationship between maternal and fetal TPs, maternal and fetal RMSSDs was found in healthy pregnancy.
The correlations between the maternal and fetal TPs, the maternal and fetal RMSSDs in the patients with severe
PE were disturbed.
Conclusion: The maternal RSA propagated its influence on the fetal autonomic nervous regulation in normal
gestation. The maternal and fetal hemodynamic coupling was reduced in PE.
Keywords: Autonomic nervous system, Respiratory sinus arrhythmia, Pre-eclampsiaBackground
Pre-eclampsia (PE) is a pregnancy-associated hypertensive
disorder that leads to maternal multiple organs failure and
fetal compromise [1–5]. The reduced endovascular
plasmatic volume is known as one of the main features of
hemodynamic regimen in pre-eclamptic maternal organ-
ism. The hypovolemia is associated with an increased
sympathetic activity [4, 5]. The elevated autonomic
balance is an evident marker of augmented peripheral
vascular tone and hypoperfusion of the end-organs [3].
The adequate trophoblastic invasion into spiral arteries
is responsible for the utero-placental hemodynamics inCorrespondence: igorlakhno71@gmail.com
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oration. The insufficient invasion causes the well-known
placental synthesis of pro-inflammatory substances and
vasoconstrictors. Placental ischemic syndrome is an
initial event in the scenario of PE [3, 4, 6]. Further endo-
thelial dysfunction, oxidative stress and thrombophilia
enhance vasoconstriction. The prediction of PE requires
the investigation of different biochemical and biophysical
markers [1–3].
Heart rate variability (HRV) is a famous approach to
the evaluation of the cardiovascular oscillations. HRV is
known as a window to the status of the human regula-
tory systems. HRV captures the impact of central and
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preclinical sign of PE [3, 5].
Since maternal and fetal circulatory systems are anatomic-
ally distinct from each other the question of their interaction
becomes a very relevant issue. The periods of maternal and
fetal cardiac synchrony were explored [7, 8]. Maternal
relaxation, physical and mental activities are known to be
associated with fetal autonomic response [9–12]. Maternal
respiratory sinus arrhythmia (RSA) was determined as
an evident factor of maternal and fetal heart rate
synchronization [7, 13].
RSA captures parasympathetic impact on the heart rate
variability (HRV). This physiological phenomenon provides
nonlinearity of the cardiac function and cardiorespiratory
synchronization [6]. RSA is known to have a modulating
impact on heart rate, cardiac output, blood pressure and
peripheral vascular tone of end-organs [2, 11–13]. The
decreased RSA is a sign of the cardiac failure [2, 4, 5]. Fetal
RSA is one of the main factors of cardiac rhythm complexity
in physiological condition. The lack of fetal parasympathetic
regulation till the last weeks of healthy pregnancy was
found [12]. But fetal respiratory activity is strongly associ-
ated with an increased vagal domain region of HRV [6, 14].
The speculation could be done that maternal RSA-
associated hemodynamic fluctuations could penetrate
through placental barrier. Therefore, these hypothesized
fluctuations could be considered a possible coupling
mechanism of the maternal and fetal circulatory systems.
The placental vascular bed acts as an intermediary of
hemodynamic oscillations. Fetal RSA is involved in its
adaptive response to chronic placental insufficiency [14].
The investigation of the relationship between maternal
and fetal HRV parameters could contribute to a better
understanding of their role in PE.
The investigation’s aim was to determine the role of
maternal RSA in regulating the fetal circulatory system
in case of healthy pregnancy and in pre-eclamptic
patients.
Method
The study protocol was approved by the Bioethics
Committee of the Kharkiv Medical Academy of Post-
graduate Education. The eligible participants were
informed about the study’s methodology, its aims, objec-
tives, indications and eventual complications before en-
rollment. Patients from the department of maternal-fetal
medicine were selected randomly. All the patients who
met the inclusion criteria gave written informed consent
to participate [15]. The inclusion criteria: diagnosed PE
based on the blood pressure higher than 140/90 mmHg
in two separate occasions 6 h apart, a positive protein-
uria test in two mild-stream urine samples collected 4 h
apart. The exclusion criteria: multiple pregnancy,
eclampsia, pre-existing medical disorders like diabetesmellitus, metabolic syndrome, cardiac diseases, renal
disease, thyrotoxycosis and chronic hypertension. If blood
pressure was 140 to 159 mmHg systolic and 90 to
109 mmHg the patient was included in mild-moderate PE
Group. Severe PE was diagnosed in case of blood pressure
was higher 160 mmHg systolic and 110 mmHg diastolic
or (and) thrombocytopenia, serum creatinine more than
1.1 mg/L, elevated blood concentration of liver transami-
nases to twice normal concentration, pulmonary oedema,
cerebral or visual disturbances. The patients who had no
gestational complications and medical disorders including
chronic infections and tobacco smoking were enrolled in
the control Group. All patients included in the study were
inhabitants of Eastern Ukraine. The study was conducted
from January 2013 to October 2015.
One hundred six patients at 34–40 weeks of gestation
were enrolled. 30 of them had healthy pregnancy and
were included into the Group I (control). In Group II,
44 pregnant women with mild-moderate PE were
observed. 32 patients with severe PE were monitored in
Group III.
All examined pre-eclamptic patients received anti-
hypertensive drugs. The choice of antihypertensive agent
was made according to the type of central maternal
hemodynamics (CMH) determined by bio-impedance
cardiography. It was estimated the values of cardiac
index (CI) and total peripheral vascular resistance
(TPVR). The hyperkinetic type of CMH was associated
with high CI and low TPVR. The pre-eclamptic women
with eukinetic type of CMH had high or normal CI and
increased TPVR. And the pre-eclamptic patients with
low CI and high TPVR had the hypokinetic type of
CMH [3]. The pregnant women with hyperkinetic type
of CMH took carvedilol 6.25–12.5 mg 2 times daily, in
case of the eukinetic type – methyldopa 250–500 mg 4
times a day and in cases of the hypokinetic one –
methyldopa 500 mg 4 times daily combined with nifedi-
pine 20 mg 2 times daily.
The fetal and maternal HRV parameters were obtained
with the fetal noninvasive computer electrocardiographic
system “Cardiolab Baby Card” (Scientific Research
Center “KhAI-Medica”, Ukraine). The Ukrainian ECG
recordings were included in the Physio Net database
[16]. The recording lasted for 10 min in the normal
maternal sitting position. The values of total power (TP)
and its spectral compounds, i.e. the very low frequency
(VLF), the low frequency (LF), the high frequency (HF)
and LF/HF ratio or sympatho-vagal balance, were deter-
mined. The temporal characteristics of the fetal HRV:
the standard deviation of normal to normal intervals
(SDNN), RMSSD, the proportion of the number of pairs
of NNs differing by more than 50 ms divided by the total
number of NNs (pNN50), the amplitude of mode (the
most frequent value of NN interval or the highest
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vals included in the pocket corresponding to the mode
measured in percentages (%) (AMo) and the stress index
– SI = AMo (%)/(2 ×Mo × Var); Var = NNmax – NNmin;
(SI) were calculated [17]. The fetal frequency bands of
HRV were explored by David M. et al. [18]. The root
mean square of successive heartbeat interval differences
(RMSSD) was considered as a RSA-related parameter
[14]. The level of RMSSD both in mother and fetus was
investigated twice within the process of treatment in
pre-eclamptic patients. The obtained fetal RR interval
time series was transformed into cardiotocographic
(CTG) tracing. The following CTG parameters were
determined: short term variation (STV), long term vari-
ation (LTV) and the number of accelerations and
decelerations.
The results thus obtained were analyzed with an
ANOVA test to compare data between groups. The
significance was set at p-value <0.05. For the statistical
analysis of relationship between X and Y, the correla-
tions coefficients were estimated with Spearman’s test.
Microsoft Office 2010 Excel software was used for statis-
tical analysis (Washington, USA).Table 2 Maternal HRV parameters in the study population
Index Group I Group II Group III
SDNN, ms 119. 8 ± 14.1 102.5 ± 9.0* 82.6 ± 10.4*⁄†
RMSSD, ms 41.6 ± 8.5 22.7 ± 6.2* 16.3 ± 4.8*⁄†
pNN5O, % 12.8 ± 3.2 6.5 ± 1.9* 1.8 ± 0.6*⁄†
AMo, % 34.6 ± 5.1 50.4 ± 11.3* 65.4 ± 12.1*/†
SI, c.u. 115.2 ± 16.8 403.9 ± 34.5* 1362.6 ± 243.4*⁄†
TP, ms2 3084.6 ± 565.7 1568.2 ± 347.2* 825.6 ± 117.9*⁄†
VLF, ms2 2361.2 ± 485.3 1130.8 ± 181.4* 541.6 ± 85.2*⁄†
LF, ms2 349.5 ± 42.6 310.3 ± 51.6* 231.9 ± 52.4*⁄†Result
The mean age values were 26.5 ± 4.1; 25.8 ± 7.2 and 25.4
± 6.3 years in Group I, Group II and Group III respect-
ively. The mean values of the gestational age were 37.1 ±
3.6; 36.9 ± 2.5 and 36.7 ± 1.8 weeks in Group I, Group II
and Group III respectively. The body mass index values in
the same groups were 24.9 ± 5.1; 28.5 ± 7.8 and 29.6 ± 8.3.
So, the mean values of body mass index in PE were signifi-
cantly higher than in healthy pregnancy Group (p < 0.05).
The study of CMH types revealed an increased both
CI and TPVR mean values in mild-moderate PE Group
(Table 1). The mean value of CI was low and the mean
value of TPVR was elevated in severe PE. Therefore, an
increase in pre- and afterload on maternal heart in
Group III was found. The hyperkinetic type of CMH
was found in 86.4% and the eukinetic one in 13.6% of
the patients in Group II. 59.4% of women in Group III
had the hypokinetic type of CMH and 40.6% of severe




Group I Group II Group III
CI, L/min/m2 3.6 ± 0.8 3.9 ± 1.2* 2.2 ± 1.1*⁄†
TPVR, dyn · s/cm5 1214.5 ± 128.2 1371.0 ± 203.4* 2460.2 ± 318.6*⁄†
*the differences were statistically significant compared to the control
group (p < 0,05)
†the differences were statistically significant compared to the group
II (p < 0,05)Hyperdynamic circulation was typical for mild-moderate
PE and hypodynamic one was found in severe PE.
Therefore, the patients of Group III had a centralization
of blood flow.
The obtained data showed a suppressed autonomic
tone in pre-eclamptic patients (Table 2). The most
considerable power was determined in the maternal VLF
domain region in all study groups. It was linked with a
relative predominance of the hypothalamic-pituitary-
adrenal axis domain region among all spectral compo-
nents of HRV in sitting position in a state of rest. The
maternal HRV in PE demonstrated an augmented activ-
ity of the central sympathetic circuit. This peculiarity
was associated with the relative increase of AMo, SI and
LF. The mean sympatho-vagal balance (LF-to-HF ratio)
values were 0.9 ± 0.3, 2.2 ± 0.6 and 4.5 ± 1.1 respectively
in Group I, Group II and Group III. This gradual growth
of sympatho-vagal balance was associated with the pro-
gredient severity of PE. The mean values of short-term
parameters: the RMSSD, the pNN5O and the HF were
lower in Group II and Group III. The lack of parasympa-
thetic regulation captured a decreased impact of RSA on
maternal hemodynamics.
The fetal HRV parameters demonstrated a suppressed
autonomic nervous regulation with an abnormal relative
elevation of the sympathetic domain region values in PE
(Table 3). The values of fetal SDNN and TP were lower
in Group II and Group III. However, the share of LF
grew relatively in the total spectra of fetal HRV in the
pre-eclamptic patients. The considerable growth of AMo
and SI values was found. The decrease of RMSSD,HF, ms2 375.4 ± 56.1 128.6 ± 31.4* 53.1 ± 13.6*⁄†
LF/HF 0.9 ± 0.3 2.2 ± 0.6* 4.5 ± 1.1*⁄†
Abbreviations: SDNN the standard deviation of normal to normal intervals,
RMSSD the root mean square of successive heartbeat interval differences,
pNN50 the proportion of NN pairs differing by more than 50 ms divided by
total number of NNs, AMo the mode amplitude (the most frequent value of
NN interval or the highest column in the histogramm) – the number of NN
intervals included into the pocket corresponding to the mode measured in
percentages (%) (AMo), SI the stress index SI = AMo (%)/(2 × Mo × Var);
Var = NNmax – NNmin, TP the total power, VLF the very low frequency, LF the
low frequency, HF the high frequency
*the differences were statistically significant compared to Group I (p < 0.05)
†the differences were statistically significant compared to Group II (p < 0.05)
Table 3 Fetal HRV parameters and CTG indices in the study
population
Index Group I Group II Group III
SDNN, ms 45.8 ± 13.1 29.4 ± 8.3* 10.2 ± 4.5*⁄†
RMSSD, ms 22.4 ± 3.4 14.2 ± 2.6* 8.1 ± 0.8*⁄†
pNN5O, % 4.2 ± 1.1 2.0 ± 0.4* 1.1 ± 0.3*⁄†
AMo, % 39.6 ± 14.1 50.2 ± 11.6* 65.9 ± 13.4*/†
SI, c.u. 169.3 ± 42.7 496.1 ± 65.8* 1467.3 ± 405.8*⁄†
TP, ms2 1513.6 ± 329.1 896.2 ± 163.5* 424.9 ± 93.7*⁄†
VLF, ms2 1252.8 ± 248.3 692.8 ± 91.3* 251.8 ± 44.2*⁄†
LF, ms2 184.3 ± 26.5 151.9 ± 34.1* 135.0 ± 19.6*⁄†
HF, ms2 77.6 ± 9.4 53.6 ± 8.2* 38.9 ± 10.4*⁄†
STV, ms 7.5 ± 2.8 6.0 ± 2.2* 4.1 ± 1.6*⁄†
LTV, ms 21.9 ± 7.1 16.1 ± 5.8* 12.6 ± 4.3*⁄†
Number of
accelerations
4.2 ± 1.8 2.7 ± 1.3* 1.2 ± 0.4*⁄†
Number of
decelerations
0.3 ± 0.1 1.5 ± 0.4* 2.8 ± 0.9*⁄†
Abbreviations: SDNN the standard deviation of normal to normal intervals,
RMSSD the root mean square of successive heartbeat interval differences,
pNN50 the proportion of NN pairs differing by more than 50 ms divided by
the total number of NNs, AMo the mode amplitude (the most frequent value
of NN interval or the highest column in the histogramm) – the number of NN
intervals included in the pocket corresponding to mode measured in
percentages (%), SI the stress index SI = AMo (%)/(2 × Mo × Var); Var = NNmax –
NNmin, TP the total power, VLF the very low frequency, LF the low frequency,
HF the high frequency
*the differences were statistically significant compared to Group I (p < 0.05)
†the differences were statistically significant compared to Group II (p < 0.05)
Table 4 Statistically significant (p < 0.05) Spearman’s correlations
between the maternal sympatho-vagal balance and CI, maternal
sympatho-vagal balance and TPVR in the study population
Pairs of parameters (X versus Y) Group I Group II Group III
Sympatho-vagal balance versus CI R = −0,30 R = −0,34 R = −0,63
Sympatho-vagal balance versus TPVR R = 0,32 R = 0,38 R = 0,70
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in Group II and Group III. So, the reduced fetal vagal
activity was found in PE. Fetal RSA according to RMSSD
value was decreased too. Therefore, sympathetic over-
activity had a modulating impact on RSA by suppressing
the power of the parasympathetic domain region. The
revealed CTG indices demonstrated the decreased fetal
heart rate reactivity in patients with PE. The values of
STV, LTV and number of accelerations were significantly
lower in patients of Group II and Group III. The num-
ber of decelerations was increased in pre-eclamptic
Groups comparatively to healthy pregnancy. The modu-
lated fetal CTG variables captured the suppression of
fetal biophysical activity and the development of fetal
distress in severe PE.
The values of maternal and fetal RMSSDs were not
changed significantly in the process of treatment. The
interval between RMSSDs assessments was different in
the study Groups. The mean interval values were 7.2 ±
1.5 days and 4.1 ± 1.8 days in Group II and Group III
respectively. Such variation was associated with the ne-
cessity of the preterm pregnancy termination in patients
with severe PE.
It was found a weak relationship between sympatho-
vagal balance and CI (R = −0.30; p < 0.05), sympatho-vagal balance and TPVR (R = 0.32; p < 0.05) in healthy
pregnancy Group (Table 4). In mild-moderate PE Group
the strength of correlation in the pairs: sympatho-vagal
balance versus CI (R = −0.34; p < 0.05) and sympatho-
vagal balance versus TPVR (R = 0.38; p < 0.05) was found
almost on the previous level. The strength of correlation
was strong in the same pairs: sympatho-vagal balance ver-
sus CI (R = −0.63; p < 0.05) and sympatho-vagal balance
versus TPVR (R = 0.70; p < 0.05) in severe PE Group.
The investigation of statistically significant correlations
between the maternal and fetal RMSSDs and TP worked
out certain regularities (Table 5). The most considerable
positive correlation was determined in the healthy preg-
nancy Group between the maternal and fetal TP (R =
0.64; p < 0.05), the maternal RMSSD and the fetal
RMSSD (R = 0.51; p < 0.05). The positive weak correl-
ation between the maternal and fetal TPs (R = 0.34; p <
0.05) was determined in Group II. The positive weak
correlation between the maternal and fetal RMSSDs in
women with mild-moderate PE (R = 0.36; p < 0.05) was
also found. No considerable relationship was worked out
between the maternal and fetal TPs (R = 0.20; p < 0.05),
the maternal and fetal RMSSDs (R = 0.18; p < 0.05) in
the patients with severe PE.
Discussion
The obtained data supported the well-known hyper-
dynamic model of the mild-moderate PE. The persistent
gestational hypervolemia with an augmented periferal
vascular tone provided an increased cardiac output.
Further hemodynamic crossover to hypovolemia and
low cardiac output manifested hypodynamic circulation
in severe PE [3]. The increased sympathetic activity in
the mild-moderate PE could be considered a compensa-
tory reaction. Such circulatory response captured an
adaptive support of the maternal organs perfusion. The
severe PE was associated with maximal sympathetic tone
amplification. High peripheral vascular resistance and
hypovolemia caused hypoperfusion of the end-organs in
severe pre-eclamptic patients. Therefore, severe PE
destroyed gestational adaptive autonomic response and
contributed to the development of cardiac failure.
A parasympathetic regulation was proved more dom-
inant than the sympathetic one in reproductive-aged
women. The parasympathetic division of autonomic ner-
vous system was found to be involved in the gestation
Table 5 Statistically significant (p < 0.05) Spearman’s correlations
between the maternal and fetal TPs, the maternal and fetal
RMSSDs in the study population
Pairs of parameters (X versus Y) Group I Group II Group III
Maternal TP versus fetal TP R = 0.64 R = 0.36 R = 0.20
Maternal RMSSD vs fetal RMSSD R = 0.51 R = 0.32 R = 0.18
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ergo-, trophotropic reactions and physiological fluid
retension [4]. Therefore, the vagal regulation demon-
strated a considerable ability to protect the gravidity in
the first half of healthy pregnancy [2, 5]. The current
study worked out an increased power of the sympathetic
domain region in the total HRV spectra of pre-eclamptic
women. It was previously determined that the sympathetic
tone was more than 3 times higher in PE than in normo-
tensive pregnant women [5]. In addition to the sympa-
thetic overactivity, a decreased parasympathetic tone was
also found in PE. The RSA is known to have a strong
relationship with the parasympathetic division of auto-
nomic nervous regulation [14]. Therefore, the suppression
of parasympathetic regulation reduced the role of RSA in
the total level of maternal HRV in PE. So, the RSA had a
slight influence on the maternal hemodynamics in PE.
The maximal increase of the sympatho-vagal balance
was a sign of the vasoconstriction and the hypoperfu-
sion. Previously the placental bed and renal vessels were
determined as the highest vascular resistance areas in PE
[3, 5]. The hypothesis that elevated intraabdominal
pressure causes renal and hepatic compartmentalization
and increases sympatho-vagal balance and decreases
RMSSD could be supported [4]. Therefore, the additional
pressure could contribute to aortocaval compression and
decreases the return of venous blood to maternal heart in
PE. The emphasis on the preload requires sympathetic
overactivity [3]. The above-mentioned autonomic modula-
tion could suppress RSA. The abnormally elevated value
of sympatho-vagal balance is known to be associated with
abdominal compartmentalization in severe PE [4].
Even reasonable usage of antihypertensive drugs failed to
decrease the autonomic balance in PE. The level of RMSSDs
in mother and fetus persists to stay on the same in the
process of treatment. Therefore, severe PE destroyed the
basis for the pregnancy vagal-mediated mechanism of
fluid retention and vasodilation. That is why the only
efficient treatment of the severe pre-eclamptic pa-
tients is a pregnancy termination. Possibly the post-
partum decrease of the intraabdominal pressure could
contribute to the sympatho-vagal balance reestablishment.
The fetal HRV demonstrated a pathological pattern of
the autonomic nervous regulation in PE. A gradual
reduction of fetal sympatho-vagal balance in the last
trimester of healthy pregnancy was previously showed[18–21]. The increased parasympathetic regulation was a
sign of the fetal maturation in the late gestation. The re-
vealed fetal hypersympatheticotonia and the lack of vagal
activity were characteristic of PE [17, 20–22]. The non-
reactive pattern of fetal CTG tracing was typical for pre-
eclamptic women. Thus, PE caused fetal distress and
changed its autonomic response. It was found in the pre-
vious study that fetal RSA in the growth restricted fetuses
was on the same level with fetal RSA in healthy pregnancy
[14]. This peculiarity was regarded as an adaptive response
in case of normal utero-placental hemodynamics. The de-
creased fetal RSA in pre-eclamptic patients was explored
in this study. PE had a negative impact on fetal RSA.
Several investigations described the fetal and maternal
cardiac rhythm synchronization [7, 8, 13]. The relationship
between maternal and fetal RMSSDs in healthy pregnancy
was found. The maternal parasympathetic regulation and
RSA had a protective impact on the circulatory response of
the mother and fetus in PE. The increased maternal auto-
nomic balance supported perfusion of the end organs and
coupling with fetal hemodynamics in mild-moderate PE
while vagal-mediated reactions were safe. Hypokinetic type
of CMH in severe PE was associated with the reduction of
RSA. The deteriorated placental perfusion and the decreased
RSA-associated hemodynamic fluctuations were due to
hemodynamic failure. Therefore, the fetal cardiovascular
system was absolutely separated from the maternal organ-
ism and lost the control in severe PE (confirmed with the
absent relationship between maternal and fetal TPs and
RMSSDs). For this reason, the loss of fetal and maternal
hemodynamic coupling could be considered a presumable
pathogenetic mechanism of the fetal distress in PE. This
hypothesis, though, requires further investigations. The
speculation could be done that the testing for maternal
sympatho-vagal balance, fetal and maternal RMSSD is
possible to be of use in future as biophysical markers of PE.
The screening for PE in III trimester is necessary for timely
preterm pregnancy termination [23]. Such active manage-
ment is a promising approach to the improvement of
perinatal and maternal outcomes.
Conclusion
The maternal RSA propagated its influence on the fetal
autonomic nervous regulation in healthy pregnancy. The
maternal and fetal hemodynamic coupling was reduced in
PE. The hypokinetic type of CMH in severe PE decreased
the RSA-mediated hemodynamic fluctuations. It was asso-
ciated with fetal TP and RMSSD considerable reduction.
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